Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1349-1356, doi:10.1016/j.jacc.2007.12.033
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dworakowski, R.
Right arrow Articles by Shah, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dworakowski, R.
Right arrow Articles by Shah, A. M.
Related Collections
Right arrowRelated Article

Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Derived Superoxide and Vascular Endothelial Dysfunction in Human Heart Failure

Rafal Dworakowski, MD, PhD*, Simon Walker*, Aziz Momin, FRCS*, Jatin Desai, FRCS*, Ahmed El-Gamel, FRCS*, Olaf Wendler, MD, PhD*, Mark T. Kearney, MD, FRCP{dagger} and Ajay M. Shah, MD, FMedSci*,*

* Cardiovascular Division, King’s College London School of Medicine, London, United Kingdom
{dagger} Leeds Institute for Genetics, Health and Therapeuticss, University of Leeds, Leeds, United Kingdom.


Figure 1
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Plasma Levels of Inflammatory Markers CRP, IL-6, and TNF-{alpha} in Subjects With or Without Heart Failure

(A) C-reactive protein (CRP) levels in control versus heart failure groups; *p < 0.05 by Mann-Whitney test. (B) CRP levels by New York Heart Association (NYHA) functional class. The linear regression was adjusted for diabetes and renal failure. (C) Interleukin (IL)-6 levels. (D) Tumor necrosis factor (TNF)-{alpha} levels.

 

Figure 2
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Vasomotor Function in Saphenous Vein Segments From Control and Heart Failure Groups

(A) Mean concentration-response relationship for acetylcholine (ACh). (B) Mean concentration-response relationship for sodium nitroprusside (SNP). (C) Relative endothelial-dependent relaxation (maximum response to ACh normalized by the maximal response to SNP). *p < 0.05 by Mann-Whitney test.

 

Figure 3
View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Superoxide Production by Human Saphenous Veins From Patients With and Without Heart Failure

(A) Superoxide production by lucigenin-enhanced chemiluminescence. *p < 0.05 by Mann-Whitney test. (B) Relationship between superoxide and New York Heart Association (NYHA) functional class using a linear regression model adjusted for diabetes and renal failure. *p < 0.05. (C) Effect of various inhibitors on superoxide production in the control and heart failure groups. *p < 0.05 by analysis of variance followed by Scheffe test, to test for differences among interventions in either the control group or the heart failure group. DPI = diphenyleneiodonium; L-NAME = NG-nitro-L-arginine methyl ester. (D) Relationship between superoxide and C-reactive protein (CRP) levels; Pearson correlation: r = 0.501; p < 0.05.

 

Figure 4
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Expression of Nox Isoforms by Real-Time Polymerase Chain Reaction in Human Saphenous Veins From Patients With and Without Heart Failure

(A) Nox2 expression; (B) Nox4 expression; (C) p47phox expression; (D) p67phox expression. *p < 0.05 by unpaired Student t test. mRNA = messenger ribonucleic acid; Nox = nicotinamide adenine dinucleotide phosphate oxidase.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement